Eleonora Swart

Head of Department

Amsterdam UMC Locatie AMC

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Pharmacy Pharmacy professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Eleonora Swart is the Head of Department at Amsterdam UMC Locatie AMC, Netherlands. Her research areas encompass pharmaceutical contamination, drug interactions, and clinical trial methodologies, as evidenced by her recent articles on particle contamination in parenteral fluids, drug development for Gaucher Disease, and myelotoxicity assessment in glioblastoma treatments. She is committed to advancing clinical practices through rigorous evaluation and innovative therapeutic strategies.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Elles Marleen Kemper

University of Amsterdam

NETHERLANDS

View details

Henrike M Hamer

Amsterdam University Medical Centers

NETHERLANDS

View details

Erik Wilms

Head of Laboratory

NETHERLANDS

View details

Imke H. Bartelink

NETHERLANDS

View details

Harm Jan Bogaard

NETHERLANDS

View details

Olaf van Tellingen

The Netherlands Cancer Institute

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eleonora Swart

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Disease–Drug–Drug Interaction of Imatinib in COVID‐19 ARDS: A Pooled Population Pharmacokinetic Analysis

Particulate contamination in parenteral fluid from glass ampoules: compliance assessment and comparative analysis of needle types and ampoule-breaking strategies

Product Development of High-Dose Ambroxol HCl Capsules for an n-of-1 Clinical Trial Involving Dutch Patients with Gaucher Disease Type 3

Examination of Particulate Contamination in Parenteral Injections and Infusions Following Fluid Withdrawal Utilizing Conventional Needles and Filter Needles: Assessment of Compliance and Comparative Analysis

A validated HPLC-MS/MS method for simultaneously analyzing curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetra-hydrocurcumin and piperine in human plasma, urine or feces

Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?

ED90 of spinal 2-chloroprocaine 1% in ambulatory knee arthroscopy up to 45 min: a randomized biased-coin- up-and-down sequential allocation trial

Implementation of a pharmacist-led transitional pharmaceutical care programme: Process evaluation of Medication Actions to Reduce hospital admissions through a collaboration between Community and Hospital pharmacists (MARCH)

Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib study.

Assessment of occupational exposure to nebulized isopropyl alcohol as disinfectant during aseptic compounding of parenteral cytotoxic drugs in cleanrooms

Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease

TRough versus AUC Monitoring of cyclosporine: A randomized comparison of adverse drug reactions in adult allogeneic stem cell recipients (TRAM study)

The effect of a Clinical Decision Support System on the frequency of dose adjustments of anticancer drugs in case of renal or hepatic dysfunction

Collaborators (6)

Elles Marleen Kemper

Henrike M Hamer

Erik Wilms

Imke H. Bartelink

Harm Jan Bogaard

Olaf van Tellingen

Make your next move.